Molecular cytogenetics of multiple drug resistance

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The refractory nature of many human cancers to multi-agent chemotherapy is termed multidrug resistance (MDR). In the past several decades, a major focus of clinical and basic research has been to characterize the genetic and biochemical mechanisms mediating this phenomenon. To provide model systems in which to study mechanisms of multidrug resistance, in vitro studies have established MDR cultured cell lines expressing resistance to a broad spectrum of unrelated drugs. In many of these cell lines, the expression of high levels of multidrug resistance developed in parallel to the appearance of cytogenetically-detectable chromosomal anomalies resulting from gene amplification. This review describes cytogenetic and molecular-based studies that have characterized DNA amplification structures in MDR cell lines and describes the important role gene amplification played in the cloning and characterization of the mammalian multidrug resistance genes (mdr). In addition, this review discusses the genetic selection generally used to establish the MDR cell lines, and how drug selections performed in transformed cell lines generally favor the genetic process of gene amplification, which is still exploited to identify drug resistance genes that may play an important role in clinical MDR.

Original languageEnglish (US)
Pages (from-to)63-89
Number of pages27
JournalCytotechnology
Volume12
Issue number1-3
DOIs
StatePublished - Feb 1 1993

Fingerprint

Multiple Drug Resistance
Cytogenetics
Cells
Gene Amplification
Pharmaceutical Preparations
Cell Line
Genes
Chemotherapy
Cloning
Genetic Phenomena
MDR Genes
Refractory materials
Amplification
Transformed Cell Line
Genetic Selection
DNA
Drug Resistance
Organism Cloning
Molecular Biology
Cultured Cells

Keywords

  • P-glycoproteins
  • cytogenetics
  • gene amplification
  • multidrug resistance
  • physical mapping

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Clinical Biochemistry
  • Cell Biology

Cite this

Molecular cytogenetics of multiple drug resistance. / Schoenlein, Patricia V.

In: Cytotechnology, Vol. 12, No. 1-3, 01.02.1993, p. 63-89.

Research output: Contribution to journalArticle

@article{95977e5c8d14409c9d41f951f5b3a94c,
title = "Molecular cytogenetics of multiple drug resistance",
abstract = "The refractory nature of many human cancers to multi-agent chemotherapy is termed multidrug resistance (MDR). In the past several decades, a major focus of clinical and basic research has been to characterize the genetic and biochemical mechanisms mediating this phenomenon. To provide model systems in which to study mechanisms of multidrug resistance, in vitro studies have established MDR cultured cell lines expressing resistance to a broad spectrum of unrelated drugs. In many of these cell lines, the expression of high levels of multidrug resistance developed in parallel to the appearance of cytogenetically-detectable chromosomal anomalies resulting from gene amplification. This review describes cytogenetic and molecular-based studies that have characterized DNA amplification structures in MDR cell lines and describes the important role gene amplification played in the cloning and characterization of the mammalian multidrug resistance genes (mdr). In addition, this review discusses the genetic selection generally used to establish the MDR cell lines, and how drug selections performed in transformed cell lines generally favor the genetic process of gene amplification, which is still exploited to identify drug resistance genes that may play an important role in clinical MDR.",
keywords = "P-glycoproteins, cytogenetics, gene amplification, multidrug resistance, physical mapping",
author = "Schoenlein, {Patricia V}",
year = "1993",
month = "2",
day = "1",
doi = "10.1007/BF00744658",
language = "English (US)",
volume = "12",
pages = "63--89",
journal = "Cytotechnology",
issn = "0920-9069",
publisher = "Springer Netherlands",
number = "1-3",

}

TY - JOUR

T1 - Molecular cytogenetics of multiple drug resistance

AU - Schoenlein, Patricia V

PY - 1993/2/1

Y1 - 1993/2/1

N2 - The refractory nature of many human cancers to multi-agent chemotherapy is termed multidrug resistance (MDR). In the past several decades, a major focus of clinical and basic research has been to characterize the genetic and biochemical mechanisms mediating this phenomenon. To provide model systems in which to study mechanisms of multidrug resistance, in vitro studies have established MDR cultured cell lines expressing resistance to a broad spectrum of unrelated drugs. In many of these cell lines, the expression of high levels of multidrug resistance developed in parallel to the appearance of cytogenetically-detectable chromosomal anomalies resulting from gene amplification. This review describes cytogenetic and molecular-based studies that have characterized DNA amplification structures in MDR cell lines and describes the important role gene amplification played in the cloning and characterization of the mammalian multidrug resistance genes (mdr). In addition, this review discusses the genetic selection generally used to establish the MDR cell lines, and how drug selections performed in transformed cell lines generally favor the genetic process of gene amplification, which is still exploited to identify drug resistance genes that may play an important role in clinical MDR.

AB - The refractory nature of many human cancers to multi-agent chemotherapy is termed multidrug resistance (MDR). In the past several decades, a major focus of clinical and basic research has been to characterize the genetic and biochemical mechanisms mediating this phenomenon. To provide model systems in which to study mechanisms of multidrug resistance, in vitro studies have established MDR cultured cell lines expressing resistance to a broad spectrum of unrelated drugs. In many of these cell lines, the expression of high levels of multidrug resistance developed in parallel to the appearance of cytogenetically-detectable chromosomal anomalies resulting from gene amplification. This review describes cytogenetic and molecular-based studies that have characterized DNA amplification structures in MDR cell lines and describes the important role gene amplification played in the cloning and characterization of the mammalian multidrug resistance genes (mdr). In addition, this review discusses the genetic selection generally used to establish the MDR cell lines, and how drug selections performed in transformed cell lines generally favor the genetic process of gene amplification, which is still exploited to identify drug resistance genes that may play an important role in clinical MDR.

KW - P-glycoproteins

KW - cytogenetics

KW - gene amplification

KW - multidrug resistance

KW - physical mapping

UR - http://www.scopus.com/inward/record.url?scp=0027737728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027737728&partnerID=8YFLogxK

U2 - 10.1007/BF00744658

DO - 10.1007/BF00744658

M3 - Article

VL - 12

SP - 63

EP - 89

JO - Cytotechnology

JF - Cytotechnology

SN - 0920-9069

IS - 1-3

ER -